THE Hyderabad-based Suven Life Sciences Ltd has been granted two product patents from the US corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases and these Patents are valid through 2029 and 2030, respectively.
展开▼
机译：总部位于海得拉巴的Suven Life Sciences Ltd从美国获得了两项与新化学实体（NCE）对应的产品专利，用于治疗与神经退行性疾病相关的疾病，这些专利分别有效期至2029年和2030年。
展开▼
